Category: Prevention
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Case Discussion (30)
September 12, 2020Optimal Antithrombotic Regimen Early & Late After Discharge in Patients Presenting With STEMI
-
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
-
-
Impact: Mavacamten for the treatment of symptomatic HCM
August 31, 2020The findings of EXPLORER HCM trial
-
Impact: Aspirin with or without Clopidogrel after TAVI
August 31, 2020The findings of POPULAR TAVI trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
-
Impact: Intracoronary infusion of bone marrow-derived mononuclear cells in AMI
August 31, 2020The findings of BAMI trial
-
Impact: Time-to-treatment of Colchicine and post-MI cardiovascular outcomes
August 31, 2020The findings of COLCOT trial
-
Save the date: Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Case Discussion (29)
August 12, 2020Pharmacotherapy approach to ACE/ARB induced AKI in HFrEF patients
-
Pharmacological approach to ACS management in patients on DOAC
August 12, 2020Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs
-
-
At a glance; FDC role in HTN Pharmacotherapy
August 9, 2020Fixed dose combination therapy in HTN Treatment
-
-
-
-
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
-
-
-
Dosage Modification of DOACs in Different Clinical Scenarios & in Renal Impairment
July 3, 2020Algorithmic approach to DOACs Dose Adjustment in CKD
-
Save the date: Optimizing Heart Failure Care Throughout the Patient Journey
June 30, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
-
Optimizing Heart Failure Care Throughout the Patient Journey
June 25, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
Low-dose Rivaroxaban in Management of PAD Patients
June 23, 2020Insights from COMPASS & VOYAGER Trials
-
-
Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients
June 23, 2020Insights from COMPASS-PCI & COMPASS-CABG Trials
-
At a glance; How dual pathway found its way into ESC guidelines?
June 7, 2020Rivaroxaban on board for CCS
-
-
-
-
-
CardioPoint (8): When to consider drug treatment in hypertension?
May 24, 2020A Brief Description on Practical Points in Cardiometabolic Field
-
Save the date: Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 13, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 12, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 10, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
-
Case Discussion (5)
May 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Antithrombotic Therapy in CCS
-
Save the date: COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 3, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
Save the date: COVID and Cardiometabolic Challenges
April 3, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
-
At a glance: ACEI and ARB in COVID-19 Era
March 19, 2020The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Save the date: COVID-19 Sharing Facts, Not the Fear
March 3, 2020Quick review on COVID-19 from an ID Perspective
-
-
-
Predicting the Risk of Post-stroke Atrial Cardiopathy
February 27, 2020An interim analysis from ACARDIA trial
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Intensive LDL lowering beyond current recommendations for MACE prevention
February 12, 2020A meta-analysis of RCTs
-
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
February 3, 2020A meta-analysis of RCTs
-
-
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
January 21, 2020A meta-analysis of RCTs
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Intensive Blood Pressure lowering and the Concerns about Falling
January 18, 2020The findings of SPRINT trial
-
Case Discussion (2)
January 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Approach to high CAC score
-
-
Cardiology Close-Up (10)
January 2, 2020Antithrombotic Therapy in Patients with Chronic Coronary Syndrome and in Sinus Rhythm
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
-
-
Case Discussion (1)
December 4, 2019Evidenced based discussion on routine cases of cardiology in clinical practice Appropriate OAC choice in AF
-
-
Inclisiran for patients with ASCVD and elevated LDL
December 2, 2019The findings of ORION-10 trial in ASCVD patients
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
November 29, 2019The findings of ORION-9 trial about Inclisiran in HeFH
-
The Efficacy and Safety of Low-Dose Colchicine after MI
November 29, 2019The findings of COLCOT trial about colchicine post-MI
-
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
November 29, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
November 29, 2019The findings of ISCHEMIA trial
-
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis
November 29, 2019The findings of RECOVERY trial
-
Anti-ischemic Medications
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
November 12, 2019Rivaroxaban versus warfarin in APS
-
Antithrombotic treatment after CABG
November 12, 2019A recent meta-analysis on post-CABG Antithrombotic therapy
-
Triglyceride Lowering and Cardiovascular Risk Reduction
November 4, 2019A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
-
Guideline Made Easy
November 3, 2019Practical Guide for treatment of high blood cholesterol Part Three
-
-
Bedtime hypertension treatment improves cardiovascular risk reduction
October 29, 2019The findings of Hygia Chronotherapy Trial
-
Peri-operative beta-blockers in non-cardiac surgery
October 24, 2019The findings of Cochrane database systematic review
-
Daily Cardiology Cath-Conference: Case no. 2
October 23, 2019The second case of Daily Cardiology Cath-Conference
-
Cardiology Close-Up (7)
October 7, 2019Pharmacologic Therapy for LDL Cholesterol Treatment Goal and Pharmacologic Therapy for LDL Cholesterol
-
Guideline Made Easy
October 3, 2019Practical Guide for treatment of high blood cholesterol Part Two
-
Ticagrelor with or without Aspirin in High-Risk patients after PCI
September 28, 2019The findings of TWILIGHT Trial
-
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
September 20, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
AF Patients on NOACs Undergoing Elective PCI or Angiography: When to Hold?
September 3, 2019Pre-procedural management of DOACs
-
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
August 24, 2019The findings of COMPASS trial
-
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
August 20, 2019OACs in Stable CAD and AF
-
-
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
August 3, 2019P2Y12 loading dose timing in PCI
-
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
July 9, 2019Preventing the cardiotoxicity of Trastuzumab
-
-
Ezetimibe for the prevention of heart disease and death
June 14, 2019The role of Ezetimibe in reducing CVD adverse outcomes
-
-
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
May 29, 2019The findings of REASTART Trial
-
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
May 25, 2019DAPT after ischemic stroke or TIA
-
CardioPoint (1):Statins-Who is eligible?-Which dose?
May 19, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
-
-
-
Cardiology Close-Up (1)
March 7, 2019Management of Antithrombotic Therapy in AFib Patients Undergoing PCI
-
Case Discussion (26)
September 4, 2017The optimal duration of beta-blocker therapy after myocardial infarction
-
-
Case Discussion (8)
July 12, 2017An ignored challenge in HTN management: Non-dippers An evidence-based discussion
-
